|
Boix F, Llorente S, Mrowiec A, Eguia J, López-Hernández R, Bernardo MV, Moya-Quiles MR, Campillo JA, Minguela A, Jimeno L, Alvarez-López MR, Muro M. Donor specific antibodies median fluorescence intensity levels are the best indicator for monitoring desensitization treatment in kidney transplant. Urol J. 2014 Jul 8;11(3):1695-8. PubMed PMID: 25015619.
AÑO: 2014; IF: 0.565
|
25015619
|
Millán O, Rafael-Valdivia L, San Segundo D, Boix F, Castro-Panete MJ, López-Hoyos M, Muro M, Valero-Hervás D, Rimola A, Navasa M, Muñoz P, Miras M, Andrés A, Guirado L, Pascual J, Brunet M. Should IFN-?, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study. Clin Immunol. 2014 Oct;154(2):141-54. doi: 10.1016/j.clim.2014.07.007. PubMed PMID: 25088788.
AÑO: 2014; IF: 3.672
|
|
López-Hernández R, Valdés M, Campillo JA, Martínez-García P, Salama H, Bolarin JM, Martínez H, Moya-Quiles MR, Minguela A, Sánchez-Torres A, Botella C, Salgado G, Miras M, Carballo F, Muro M. Pro- and anti-inflammatory cytokine gene single-nucleotide polymorphisms in inflammatory bowel disease. Int J Immunogenet. 2015 Feb;42(1):38-45. doi: 10.1111/iji.12160. PubMed PMID: 25359546.
AÑO: 2015; IF: 1.174
|
|
Campillo JA, López-Hernández R, Martínez-Banaclocha H, Bolarín JM, Gimeno L, Mrowiec A, López M, Las Heras B, Minguela A, Moya-Quiles MR, Legáz I, Frías-Iniesta JF, García-Alonso AM, Álvarez-López MR, Martínez-Escribano JA, Muro M. MHC class I chain-related gene a diversity in patients with cutaneous malignant melanoma from southeastern Spain. Dis Markers. 2015;2015:831864. doi: 10.1155/2015/831864. PubMed PMID: 25838620; PubMed Central PMCID: PMC4370202.
AÑO: 2015; IF: 2.137
|
|
Muro M, Mrowiec A. Interleukin (IL)-1 Gene Cluster in Inflammatory Bowel Disease: Is IL-1RA Implicated in the Disease Onset and Outcome? Dig Dis Sci. 2015 May;60(5):1126-8. doi: 10.1007/s10620-015-3571-6. PubMed PMID: 25875754.
AÑO: 2015; IF: 2.516
|